Signition LP’s Madrigal Pharmaceuticals MDGL Stock Holding History

Signition LP’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,000	Closed	-$280K	–	362
2018 Q2	$280K	Buy	+1,000	New	+$176K	0.17%	168

Other funds holding MDGL

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Signition LP's MDGL Position: Q3 2018 in Review

Signition LP sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2018, closing a stake of 1,000 shares — an estimated $280K sold.

Signition LP first reported a position in MDGL in Q2 2018 and held it in 1 quarter. The position peaked at $280K in Q2 2018. 156 funds tracked by Wall St. Rank hold MDGL as of Q3 2018.

Signition LP reported no remaining Madrigal Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Signition LP sold 1,000 Madrigal Pharmaceuticals shares in Q3 2018, an estimated $280K.
Signition LP first reported a position in Madrigal Pharmaceuticals in Q2 2018 and held it in 1 quarter.
Signition LP's Madrigal Pharmaceuticals position peaked at $280K in Q2 2018.
156 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2018.

Based on Signition LP's 13F filing for Q3 2018, filed 1 Nov 2018.